Roche

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. 

CEO
Thomas Schinecker
CEOThomas Schinecker
Employees
112,774
Employees112,774
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1896
Founded1896
Employees
112,774
Employees112,774

RHHBY Key Statistics

Market cap
380.14B
Market cap380.14B
Price-Earnings ratio
24.13
Price-Earnings ratio24.13
Dividend yield
1.70%
Dividend yield1.70%
Average volume
1.01M
Average volume1.01M
High today
$59.18
High today$59.18
Low today
$58.33
Low today$58.33
Open price
$59.02
Open price$59.02
Volume
176.79K
Volume176.79K
52 Week high
$61.75
52 Week high$61.75
52 Week low
$47.05
52 Week low$47.05

RHHBY News

Benzinga 3d
Roche Wins Dual FDA Approvals for Breast Cancer and Chronic Kidney Disease Therapies - Benzinga

...

Roche Wins Dual FDA Approvals for Breast Cancer and Chronic Kidney Disease Therapies - Benzinga
TipRanks 4d
Roche receives FDA De Novo authorization for cobas pro i 601 platform

Roche (RHHBY) announced that the FDA has granted De Novo authorization for the cobas pro i 601 platform with the Ionify Gabapentin assay, components of its coba...

Analyst ratings

46%

of 24 ratings
Buy
45.8%
Hold
45.8%
Sell
8.3%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.